Blog
Specific and nonspecific tumor markers: clinical significance in diagnosis
Oncological diagnostics is developing rapidly, and laboratory tumor markers have become an important tool. However, the interpretation of tumor markers requires caution: not all markers are equally informative for screening or confirmation of diagnosis.
Tumor markers are divided into specific and nonspecific, depending on their relationship to specific types of tumors. This division has practical significance for the physician, especially in matters of monitoring treatment, detecting relapses and assessing the risk of progression.
What is a tumor marker?
Tumor marker is a substance that:
or directly produced by a tumor cell;
or produced by the body in response to tumor development.
They can be protein, enzymatic, hormonal or immunological. Their appearance in biological fluids does not always mean a malignant formation, which necessitates a differentiated approach.
Specific tumor markers: guidelines for targeted diagnostics
These markers have a clear association with a specific type of cancer and are widely used in clinical practice. Their advantage is high diagnostic accuracy in certain forms of the disease.
| Tumor marker | Tumor type | Additional information |
|---|---|---|
| PSA (prostate-specific antigen) | Prostate cancer | Possible growth in benign hyperplasia |
| AFP (alpha-fetoprotein) | Hepatocellular carcinoma, germ cell tumors | Also increases in cirrhosis |
| CA 125 | Ovarian cancer | Increased in endometriosis, peritonitis |
| CA 19-9 | Cancer of the pancreas, biliary system | Low efficiency for early diagnosis |
| CA 15-3 | Breast cancer | Correlates with stage and metastases |
| Calcitonin | Medullary thyroid cancer | High-fidelity marker |
These markers are used not only at the detection stage, but also:
for monitoring the effectiveness of chemotherapy or surgery;
for early detection of relapse.
Nonspecific tumor markers: broad but limited diagnostics
Nonspecific tumor markers not tied to one type of tumor, often change in various pathological conditions — both oncological and non-oncological.
| Tumor marker | Possible reasons for the growth | Limitation |
|---|---|---|
| CEA (carcinoembryonic antigen) | Stomach, intestinal, lung cancer, smoking, chronic liver disease | Elevated in 20–40% smokers |
| β-hCG (β-subunit of chorionic gonadotropin) | Germinogens, placental tumors, pregnancy | Mandatory interpretation with clinical data |
| NSE (neurospecific enolase) | Small cell lung cancer, neuroendocrine tumors, stroke | High sensitivity in progression |
| LDH | Non-Hodgkin lymphoma, melanoma, hemolysis, infarction | Marker of general proliferative activity |
Nonspecific markers are often used for preliminary assessment of the condition, but they cannot be the sole basis for making a diagnosis.
What does the research say?
WHO
The World Health Organization indicates that no tumor marker has 100% sensitivity and specificity. It is recommended to use them as part of a comprehensive diagnosis.
FDA
The US Food and Drug Administration (FDA) recognizes PSA, AFP, CA 125, CEA as markers with proven clinical efficacy, but not as a screening tool for the general population without symptoms.
Mayo Clinic
According to Mayo Clinic research, the level CA 19-9 increases not only in pancreatic cancer, but also in chronic pancreatitis and gallstone disease, which reduces its prognostic value in the early stages.
Practical conclusions for the doctor and the patient
Tumor markers do not replace instrumental methods (ultrasound, CT, MRI, biopsy).
Increasing even a highly specific marker requires confirmation by other examinations.
In dynamics, tumor markers allow detect recurrence 1–3 months earlier than visual methods.
To assess the risk, it is worth using combined panels tumor markers (e.g. ROMA, HE4 + CA 125).
Tumor markers should not be used as the sole screening tool. without clinical symptoms.
Tumor markers are not a magic wand, but a precise tool in the hands of an experienced physician. Their value increases when used correctly: in conjunction with history, symptoms, imaging methods, and biopsy results.
